ANI PHARMACEUTICALS, INC.
About ANI PHARMACEUTICALS, INC.
ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified biopharmaceutical company serving patients in need by developing, manufacturing, and marketing high quality branded and generic prescription pharmaceutical products, including for diseases with high unmet medical need. The company focuses on delivering sustainable growth by building a successful Purified Cortrophin Gel franchise and strengthening its generics business with enhanced development capability. It is based in Princeton, New Jersey.
- 🔗 ANI Pharmaceuticals Announces Pricing of $75 Million Public Offering of Common Stock - ANI Pharmaceuticals, Inc.
- 🔗 ANI Pharmaceuticals, Inc. Company Overview, Contact Details & Competitors | LeadIQ
- 🔗 ANI Pharmaceuticals, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
- 🔗 ANI Pharmaceuticals - 2026 Company Profile, Funding & Financials - Tracxn
- 🔗 Investor FAQs - ANI Pharmaceuticals, Inc.
Investors
Not disclosed in the source filing. Form D filings do not list investors — StreetZero surfaces them from news where available.
Key highlights
- Completed $75 million public offering of common stock in May 2023.
- Raised $307M in Post IPO Debt in August 2024.
- Revenue estimated in the $250M-$500M range.
- Focuses on Purified Cortrophin Gel franchise and generics portfolio.
Ask StreetZero about ANI PHARMACEUTICALS, INC.
Put our AI to work on this deal.
Similar companies
Other Public Equity (NASDAQ) deals, ranked by Signal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account